Metformin and Octreotide acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metformin (metformin hydrochloride) and Octreotide acetate (octreotide acetate). Common drug interactions include back pain among females and blood pressure systolic increased among males.

The phase IV clinical study analyzes what interactions people have when they take Metformin and Octreotide acetate. It is created by eHealthMe based on reports of 85 people who take the same drugs from the FDA, and is updated regularly.

What is Metformin?

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 465,354 Metformin users. Check the latest studies of Metformin.

What is Octreotide acetate?

Octreotide acetate has active ingredients of octreotide acetate. eHealthMe is studying from 2,449 Octreotide acetate users. Check the latest studies of Octreotide acetate.



On Jun, 10, 2026

85 people who take Metformin and Octreotide acetate together, and have interactions are studied.

Metformin and Octreotide acetate drug interactions.

What are the common drug interactions of Metformin and Octreotide Acetate, by gender? *:

female:

  1. Back pain
  2. Dyspnoea (difficult or laboured respiration)
  3. Headache (pain in head)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Blood glucose increased
  6. Blood pressure decreased
  7. Drug ineffective
  8. Heart rate decreased
  9. Pyrexia (fever)
  10. Arthralgia (joint pain)

male:

  1. Blood pressure systolic increased
  2. Diarrhoea
  3. Haemoglobin decreased
  4. Pulmonary mass
  5. Tooth abscess (pus formation in tooth)
  6. Tooth infection
  7. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
  8. Abdominal distension
  9. Asthenia (weakness)
  10. Epistaxis (bleed from the nose)

What are the common drug interactions of Metformin and Octreotide Acetate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Drug ineffective
  2. Haematocrit decreased
  3. Haemoglobin decreased
  4. Red cell distribution width increased
  5. Addison's disease (addison's disease, a hormonal disorder disease)

40-49:

  1. Hyperglycaemia (high blood sugar)
  2. Arthralgia (joint pain)
  3. Blood triglycerides increased
  4. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  5. Cyst (a closed sac)
  6. Diarrhoea
  7. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  8. Dry eye (lack of adequate tears)
  9. Dry skin
  10. Emotional distress

50-59:

  1. Pain in extremity
  2. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
  3. Weight decreased
  4. Abnormal faeces (abnormal stool)
  5. Anal abscess
  6. Angina pectoris (chest pain due to ischemia of the heart muscle)
  7. Anxiety
  8. Blood magnesium decreased
  9. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  10. Chills (felling of cold)

60+:

  1. Fatigue (feeling of tiredness)
  2. Diarrhoea
  3. Heart rate decreased
  4. Blood glucose increased
  5. Erythema (redness of the skin)
  6. Nausea (feeling of having an urge to vomit)
  7. Pyrexia (fever)
  8. Asthenia (weakness)
  9. Fall
  10. Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

  1. Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 14 people, 16.47%
  2. Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 12 people, 14.12%
  3. Carcinoid Tumor: 9 people, 10.59%
  4. Type 2 Diabetes: 7 people, 8.24%
  5. Neuroendocrine Tumor: 7 people, 8.24%
  6. Diarrhea: 7 people, 8.24%
  7. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 6 people, 7.06%
  8. Pain: 6 people, 7.06%
  9. High Blood Pressure: 6 people, 7.06%
  10. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 5 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Metformin and Octreotide acetate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Metformin and Octreotide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Metformin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Octreotide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metformin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Octreotide acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on metformin hydrochloride and octreotide acetate (the active ingredients of Metformin and Octreotide acetate, respectively), and Metformin and Octreotide acetate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: